Events Search and Views Navigation

Event Views Navigation

Today

Career Workshop for PhDs and Postdocs

Boyer 159 611 Charles E. Young Dr. E., Los Angeles, CA, United States

Join us for a tailored workshop designed to empower you with the skills and knowledge needed to excel in the competitive landscape of academia, industry, and beyond. Learn from experienced professionals, gain valuable insights, and expand your network.  Guest Speakers: • Kathrin Burch, Associate Manager, Statistical Genetics, Regeneron • Max Shokhirev, Head of Bioinformatics at […]

W13: Genetic Analysis (VCF-Plink)

529 Boyer Hall 611 Charles E Young Dr E,, Los Angeles, CA, United States

High-throughput sequencing technologies have allowed researchers to extract DNA at the individual, population, and species levels. In this workshop, students will learn how to analyze and interpret population-level genetic information with PLINK and R. Students will also be exposed to the literature on the different topics, followed by hands-on exercises and paper discussion.

Research-in-Progress (RIP) Seminar: Jonathan Mah (Garud-Lohmueller), Graduate Student in Bioinformatics Interdepartmental Program

Boyer Hall 159

TITLE: "Inference of the demographic histories and selective effects of human gut commensal microbiota over the course of human history" ABSTRACT: Despite the importance of gut commensal microbiota to human health, there is little knowledge about their evolutionary histories, including their demographic histories and distributions of fitness effects (DFE) of mutations. Here, we infer the […]

Research-in-Progress (RIP) Seminar: Raag Agrawal (Boutros), Graduate Student in Genetics & Genomics, UCLA/Caltech MSTP

Boyer Hall 159

TITLE: "Discovering biomarkers for predicting response to neo-adjuvant ADT and radionuclide treatment in high-risk prostate cancer" ABSTRACT: Prostate cancer is the number one cause of cancer death in non-smoking American men. Next generation treatments for prostate cancer include androgen deprivation therapy (ADT) drugs such as Enzalutamide and radionuclide treatments like Lu-PSMA-617. While both of these […]